Cargando…
Baicalein inhibits cell growth and increases cisplatin sensitivity of A549 and H460 cells via miR‐424‐3p and targeting PTEN/PI3K/Akt pathway
Lung cancer is the leading cause of death in individuals with malignant disease. Non‐small‐cell lung cancer (NSCLC) is the most common type of lung cancer, and chemotherapy drugs such as cisplatin are the most widely used treatment for this disease. Baicalein is a purified flavonoid compound that ha...
Autores principales: | Lu, Chunya, Wang, Huaqi, Chen, Shanshan, Yang, Rui, Li, Hui, Zhang, Guojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867147/ https://www.ncbi.nlm.nih.gov/pubmed/29392841 http://dx.doi.org/10.1111/jcmm.13556 |
Ejemplares similares
-
Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1
por: Cheng, Ruirui, et al.
Publicado: (2022) -
Silencing BMP-2 expression inhibits A549 and H460 cell proliferation and migration
por: Chu, Heying, et al.
Publicado: (2014) -
Down-regulation of miR-424 inhibited the metastasis of endometrial carcinoma via targeting PTEN/PI3K/AKT signaling pathway
por: Lu, Yongwei, et al.
Publicado: (2023) -
MALAT1/miR-101-3p/MCL1 axis mediates cisplatin resistance in lung cancer
por: Wang, Huaqi, et al.
Publicado: (2017) -
A Mixture of Baicalein, Wogonin, and Oroxylin-A Inhibits EMT in the A549 Cell Line via the PI3K/AKT-TWIST1-Glycolysis Pathway
por: Cao, Hui-Juan, et al.
Publicado: (2022)